SULT1A1 and neoplasm: Using TONs of SULTs as a measurement of catalytic efficiency, we found that with the exception of that for SULT1A1, TON did not change in the tumor vs. pericarcinomatous tissues, even with a large decrease in activities or expressions in 90% of the subjects.